Overall, taurine, especially at higher doses, exhibits significant potential for osteoporosis management by modulating key genetic pathways by reducing PPARγ and increasing SOD1 to protect against oxidative stress, and downregulating SOST and DKK1 to promote bone formation and simultaneously inhibit bone resorption. The gene discussed is SOD1; the disease is osteoporosis.